The Asian Scientist 100
Emi Ito
Institution
Osaka University
Country
Japan
Field
Life Sciences
Ito was awarded the 2023 JSPS Ikushi Prize by the Japan Society for the Promotion of Science for her research on unraveling the role of host-derived metabolites in the development of innate-type T cells.
(Photo: Osaka University)
AWARDS
- 2023 JSPS Ikushi Prize
Related articles
Asia’s Rising Scientists: Ho Ghim Wei
To meet the world’s rising energy demands, Associate Professor Ho Ghim Wei is leveraging solar technologies for a brighter and more sustainable future.
WEF 2020 Young Scientists Include Eight From Asia
From neuroscience to satellite research, eight scientists based in Asia were honored as part of the World Economic Forum’s Class of 2020 Young Scientists.
Cultivating CRISPR For Crops
For gene editing technologies like CRISPR to make a positive impact on agriculture, they must be embraced by companies both big and small. Corteva Agriscience is encouraging open innovation to help bridge the gap.
Nature’s Editor-in-Chief On Publishing In The COVID-19 Era (VIDEO)
Don’t miss our next Wildtype Media Expert Opinion webinar with Dr. Magdalena Skipper, editor-in-chief of Nature.
Asia’s Scientific Trailblazers: Chikashi Toyoshima
In seeking to visualize proteins at the smallest scale, Professor Chikashi Toyoshima has cemented his place as one of structural biology’s most impactful researchers.
Nobel Laureate Tasuku Honjo Refutes Link To ‘Man-Made’ Coronavirus Claim
2018 Nobel laureate Tasuku Honjo has refuted any link to social media posts that claim the SARS-CoV-2 virus was 'man-made' or 'invented' in a lab.
Tasuku Honjo Wins 2018 Nobel Prize in Physiology or Medicine
Professor Tasuku Honjo was recognized for his discovery of PD-1, which paved the way for modern cancer immunotherapy.
Red Pandas Actually Two Distinct Species
Using population genomics, scientists have confirmed that the two red panda species have different evolutionary histories.
Dealing Coronavirus A Knockout Punch
As the COVID-19 pandemic continues to rage around the world, old therapeutics are being given a second chance to fight a new foe. Here are seven of them.